For the Inventor, By the Inventor

Enter assignee name

Budapest, Hungary

Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag

USPTO Granted Patents = 16

EPO Patents = 13

Forward Citations = 2

Loading Chart...

Loading Chart...

87 inventors (with patents filed for the assignee):

Gyula Simig (7 out of 55 patents)

Márta Porcs-Makkay (6 out of 9 patents)

Tibor Mezei (6 out of 36 patents)

4. Kálmán Nagy (6 out of 8 patents)

5. Balazs Volk (5 out of 12 patents)

6. Gyula Lukacs (5 out of 7 patents)

7. Jozsef Barkoczy (5 out of 20 patents)

8. Gyorgy Ruzsics (4 out of 4 patents)

9. Ferenc Lorant Bartha (4 out of 10 patents)

10. Gyula Lukács (4 out of 5 patents)

11. Maria Tothne Lauritz (3 out of 4 patents)

12. Gyorgyi Kovanyine Lax (3 out of 4 patents)

13. Eva Sipos (3 out of 4 patents)

14. Gyorgy Krasznai (3 out of 6 patents)

15. Balázs Volk (3 out of 9 patents)

16 patents: Sort by Forward Citations

1. 9775908 - Pharmaceutical preparations containing highly volatile silicones (2017-10-03),

2. 9556163 - Process for the preparation of a rivaroxaban and intermediates formed in said process (2017-01-31),

3. 9321733 - Crystalline pharmaceutically active ingredients (2016-04-26),

4. 9260421 - Pharmaceutical intermediates and process for the preparation thereof (2016-02-16),

5. 9174945 - Rosuvastatin zinc salt (2015-11-03),

6. 9169265 - Process for preparing pharmaceutical compounds and intermediate compounds (2015-10-27),

7. 9133132 - Method for the preparation of high-purity pharmaceutical intermediates (2015-09-15),

8. 9040696 - Method for preparing rosuvastatin salts (2015-05-26),

9. 8883860 - Method for purifying diatomaceous earth (2014-11-11),

10. 8394993 - Process for the preparation of pharmaceutical intermediates (2013-03-12),

11. 8318743 - Medicament for the enhancement of cognitive function and neuroprotection (2012-11-27),

12. 8217200 - [object Object] (2012-07-10),

13. 8097616 - Process for preparation of high-purity meloxicam and meloxicam potassium salt (2012-01-17),

14. 7981884 - Process for the preparation of olanzapine (2011-07-19),

15. 7960558 - Pharmaceutical intermediate for synthesizing ACE inhibitors and the use thereof (2011-06-14),

EGIS Gyógyszergyár Nyrt. is a Hungarian pharmaceutical company that focuses on the development, production, and marketing of innovative and generic medicines. With a history dating back to 1913, EGIS has become one of the largest pharmaceutical companies in Central and Eastern Europe. They aim to improve the quality of life for patients by providing high-quality, affordable medications. EGIS operates globally, with a strong presence in more than 30 countries. Their product portfolio includes prescription drugs, over-the-counter medicines, and active pharmaceutical ingredients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

16 Patents

#13 in Budapest

#21 in Hungary

#36,634 in the World

Budapest, Hungary

Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag

Forward Citations = 2

87 inventors:

Gyula Simig (7 out of 55 patents)

Márta Porcs-Makkay (6 out of 9 patents)

Tibor Mezei (6 out of 36 patents)

4. Kálmán Nagy (6 out of 8 patents)

5. Balazs Volk (5 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…